People · Operator
Named in public records as an officer, director or promoter · active 2012–2013 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| X Body Inc | — | Biotechnology | Series A | $10.3M | $96.3M | 2013 |
| X-Rx, Inc. | — | Pharmaceuticals | Series A | $8.5M | $263.3M | 2012 |
Jeffrey W. Troderman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey W. Troderman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard W. Wagner | 2 | 3 |
| Lee Babiss | 1 | 5 |
| B. Judd Hartman | 1 | 3 |
| Daniel G. Darazsdi | 1 | 2 |
| William J. Sharbaugh | 1 | 2 |
| Gordon W. Binder | 1 | 1 |
| Charles H. Munn, Jr. | 1 | 1 |
| Brant W. Binder | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.